New Class of Biomarkers Predicts Cancer Patient Treatment Response
A new class of blood-based biomarkers could be developed into improved or orthogonal tests for predicting tumor responses to treatment.
Read MorePosted by Melanie Hamilton-Basich | May 26, 2023 | Hematology & Serology, Lung Cancer |
A new class of blood-based biomarkers could be developed into improved or orthogonal tests for predicting tumor responses to treatment.
Read MorePosted by Chris Wolski | May 19, 2023 | Disease States |
The accuracy of polygenic scores (PGSs) varies between individuals across a continuum of genetic ancestry.
Read MorePosted by Chris Wolski | May 19, 2023 | Miscellaneous |
AMP has published a report to establish recommendations for standardizing germline variants detected by next-generation sequencing (NGS).
Read MorePosted by Chris Wolski | May 18, 2023 | Pancreatic |
An artificial intelligence tool has successfully identified those at the highest risk for pancreatic cancer up to 3 years before diagnosis.
Read MorePosted by Chris Wolski | May 18, 2023 | Prostate |
Experts argue that “test by request” have led to higher PSA testing and clear medical harm, with minimal benefit and inequity.
Read More